'
Zydus
Lifesciences hosted a conference call on Feb 10, 2026. In the conference call,
the company was represented by, Dr. Sharvil Patel, Managing Director.
Key takeaways of the call
In
Q3 FY26, the India Formulations business grew 12.9% YoY, Consumer Wellness was
up 113.4% YoY, North America Formulations rose 16.4% YoY, and International
Formulations increased 38.2% YoY. Revenue from the API segment increased 25.8%
YoY, and the Alliances & Others segment was down 31% YoY.
In
Q3 FY26, the India business contributed 25% to the total revenue, North America
Formulations contributed 41%, International Formulations 12%, Consumer Wellness
14%, API & Alliance 3%, and Medtech 5%.
During
9M FY26, the India business contributed 25% to the total revenue, North America
Formulations contributed 45%, International Formulations 12%, Consumer Wellness
13%, API & Alliance 3%, and Me...
Pleaselogin & subscribe to view the full report.
More Reports
|
|